NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 54 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $34,000 | +30.8% | 244,756 | 0.0% | 0.00% | – |
| Q4 2018 | $26,000 | -54.4% | 244,756 | 0.0% | 0.00% | – |
| Q3 2018 | $57,000 | +1.8% | 244,756 | 0.0% | 0.00% | – |
| Q2 2018 | $56,000 | -36.4% | 244,756 | 0.0% | 0.00% | – |
| Q1 2018 | $88,000 | +1.1% | 244,756 | 0.0% | 0.00% | – |
| Q4 2017 | $87,000 | -14.7% | 244,756 | 0.0% | 0.00% | – |
| Q3 2017 | $102,000 | -17.7% | 244,756 | 0.0% | 0.00% | – |
| Q2 2017 | $124,000 | -12.1% | 244,756 | -0.0% | 0.00% | – |
| Q1 2017 | $141,000 | -1.4% | 244,877 | +9.0% | 0.00% | – |
| Q4 2016 | $143,000 | -27.8% | 224,558 | +3.9% | 0.00% | – |
| Q3 2016 | $198,000 | +72.2% | 216,130 | -0.2% | 0.00% | – |
| Q2 2016 | $115,000 | -92.1% | 216,635 | -86.0% | 0.00% | – |
| Q1 2016 | $1,461,000 | -29.0% | 1,545,505 | -0.1% | 0.00% | -100.0% |
| Q4 2015 | $2,057,000 | -40.4% | 1,546,785 | +2.1% | 0.00% | 0.0% |
| Q3 2015 | $3,453,000 | +43.0% | 1,514,425 | +1.0% | 0.00% | 0.0% |
| Q2 2015 | $2,415,000 | -2.6% | 1,500,065 | -3.8% | 0.00% | 0.0% |
| Q1 2015 | $2,480,000 | -12.3% | 1,559,581 | +4.2% | 0.00% | 0.0% |
| Q4 2014 | $2,828,000 | +35.4% | 1,496,625 | -5.4% | 0.00% | 0.0% |
| Q3 2014 | $2,088,000 | +1.0% | 1,582,355 | +13.2% | 0.00% | 0.0% |
| Q2 2014 | $2,068,000 | -26.4% | 1,397,224 | -8.0% | 0.00% | 0.0% |
| Q1 2014 | $2,808,000 | -19.3% | 1,518,360 | -9.7% | 0.00% | 0.0% |
| Q4 2013 | $3,481,000 | -21.1% | 1,681,618 | +1.1% | 0.00% | -50.0% |
| Q3 2013 | $4,410,000 | +5.3% | 1,663,997 | +6.1% | 0.00% | 0.0% |
| Q2 2013 | $4,187,000 | – | 1,568,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|